Fundraising FoxJJDC — Full Portfolio
16 tracked investments · listed companies and verified rows first
Contineum is a biopharmaceutical company developing small molecule drug candidates to treat inflammatory and fibrotic diseases by modulating critical disease pathways.
BiotechHealthtech
Carmine Stengone(President and Chief Executive Officer)inPeter T. Slover(Chief Financial Officer)inDaniel S. Lorrain(Chief Scientific Officer)inTimothy R. Watkins(Chief Medical Officer and Head of Development)in
Co-investorsHadean VenturesRed Tree VentureSamsara BioCapitalCasdin CapitalFranklin TempletonSectoral Asset Management+1 more
Protagonist is a company that emphasizes a diverse and inclusive corporate culture as central to its innovation, with stated goals of creating wins for its organization and for patients.
BiotechHealthtechMilpitas, US
Dinesh V. Patel, PhD(Executive Officer, Director)Dinesh Patel(President & Chief Executive Officer)
BoardAsish K. Xavier, Ph.D.(Director)Michael Panaccio, Ph.D.(Director)Armen Shanafelt, Ph.D.(Director)Paul F. Truex(Director)
Co-investorsAisling CapitalCanaan PartnersRA CapitalStarfish VenturesJohnson & Johnson Innovation – JJDCLilly Ventures
Accent Therapeutics is a biotechnology company focused on discovering and developing small molecule drugs to improve health outcomes for cancer patients.
BiotechHealthtechLongevity
Co-investorsAtlas VentureDroia VenturesEcoR1 CapitalGV (Google Ventures)The Column GroupAbbVie+3 more
Healthcare technology company delivering real-world evidence for life sciences companies, payers, and regulators.
Data & InfrastructureDigital HealthHealthtechNew York, US
Sebastian G. Schneeweiss(Director)William Geary(Director)inJeremy Rassen(Founder)Kyle Armbrester(Chief Executive Officer)inSebastian Schneeweiss(Founder)
Co-investorsB Capital GroupB4 CapitalBlue LionBlue Lion GlobalFlare Capital PartnersForesite Capital+8 more
.jpeg){kind=logo}
BrainsGate develops a neurostimulation therapy for stroke patients based on stimulation of the sphenopalatine ganglion (SPG) to increase cerebral blood flow.
BiotechHealthtechMedical Devices
Co-investorsAgate Medical Investments LPCipio PartnersElron VenturesPitangoSpero Ventures
Cellular Origins provides automated cell therapy manufacturing solutions through its Constellation platform, which integrates robotics and digital management to enable GMP-compliant scaling of cell therapies with minimal process modification.
Advanced ManufacturingBiotechRoboticsCambridge, GB
Alex Lang(Founder)
Co-investorsHighland EuropeNYBC VenturesBusiness Growth FundJohnson & Johnson Innovation – JJDC
Fusion Pharma develops targeted alpha therapeutics that link alpha-emitting medical isotopes to molecules targeting biomarkers on cancer cell surfaces to selectively kill tumor cells.
BiotechHealthtech
John Valliant(Founder)in
Co-investorsFACIT (Fight Against Cancer Innovation Trust)Genesys CapitalHealthCapLumira VenturesPivotal Life SciencesSeroba Life Sciences+6 more
Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.
AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB
Michael B. Brenner(Founder)Chris Buckley(Founder)Mark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)Lindsey Rolfe(Chief Medical Officer)in
Co-investorsGV (Google Ventures)SV Health InvestorsForbionJohnson & Johnson Innovation – JJDCNorthpond Ventures
Nucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets.
AI & Machine LearningBiotechDeep Tech
Co-investorsM VenturesOxford Science EnterprisesPfizer Venture InvestmentsBritish Patient CapitalPfizer Ventures
Developing novel KRAS degraders.
Burlington, US
Huaixiang Hao(Founder)in
Co-investorsMRL Ventures FundBioTrack Capital
BiotechLexington, US
Victoria M. Richon(Executive Officer, Director)in
BoardCameron Wheeler(Director)Jonathan Root(Director)Laurence Lasky(Director)
Co-investorsAvego BioScience CapitalOUP (Osage University Partners)Peregrine VenturesAbbVieDeerfield Management CompanyNovartis Venture Fund+3 more
HealthtechCambridge, US
Adam Rosenberg(Executive Officer, Director)inAnkit Mahadevia(Founder)in
BoardBruce Booth(Director)inKees Been(Director)Samantha Singer(Director)
Co-investorsGV (Google Ventures)Hatteras Venture PartnersThird Point VenturesAtlas VentureRemeditex Ventures
Ronovo Surgical develops the Carina surgical robotics platform, including a vision system and instruments, for use by surgeons and hospitals.
HealthtechMedical DevicesRoboticsShanghai, CN
John Ma(Founder)inYing Mao(Founder)in
Co-investorsGranite AsiaINCE CapitalVivo CapitalLilly Asia Ventures
Verana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechSan Francisco, US
Mark Blumenkranz, MD(Co-Founder, Verana Health and Lagunita Biosciences)Sujay Jadhav(Chief Executive Officer)in
Co-investorsNovo HoldingsBreyer CapitalDeerfield Management CompanyGV (Google Ventures)Merck Global Health Innovation FundMSD Global Health Innovation Fund+7 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.